Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
快手-W
01024
5
京东健康
06618
| (FY)2024/11/30 | (Q2)2024/05/31 | (Q1)2024/02/29 | (FY)2023/11/30 | (Q4)2023/11/30 | (Q3)2023/08/31 | (Q2)2023/05/31 | (Q1)2023/02/28 | (FY)2022/11/30 | (Q4)2022/11/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | -9.15%39.7亿 | -29.92%9.52亿 | -0.03%10.01亿 | 2.37%43.7亿 | -34.41%10.23亿 | 45.18%9.87亿 | 2.40%13.59亿 | 42.64%10.01亿 | 35.59%42.68亿 | 15.38%15.6亿 |
| 主营业务成本 | -13.51%28.2亿 | -32.73%6.93亿 | -2.25%7亿 | 6.17%32.6亿 | -38.62%6.98亿 | 67.60%8.16亿 | 7.94%10.3亿 | 45.39%7.16亿 | 36.96%30.71亿 | 6.56%11.37亿 |
| 毛利 | 3.68%11.5亿 | -21.11%2.59亿 | 5.53%3亿 | -7.37%11.09亿 | -23.10%3.26亿 | -11.48%1.71亿 | -11.80%3.29亿 | 36.15%2.85亿 | 32.19%11.98亿 | 48.35%4.23亿 |
| 营业费用 | -4.32%8.73亿 | -2.98%2.24亿 | 9.31%2.4亿 | 4.62%9.13亿 | -2.24%2.51亿 | 8.83%2.11亿 | 6.29%2.31亿 | 7.47%2.2亿 | 12.09%8.73亿 | 32.57%2.57亿 |
| 营业利润 | 40.82%2.77亿 | -64.10%3,498.5万 | -7.28%6,008.9万 | -39.57%1.96亿 | -55.29%7,443万 | -3,717.44%-4,027.4万 | -37.17%9,745.1万 | 1,336.05%6,480.9万 | 154.92%3.25亿 | 81.70%1.66亿 |
| 营业外利息收入与支出净额 | -80.71%40万 | -46.04%10.9万 | -64.75%19万 | -14.08%207.4万 | -33.85%38.5万 | -5.11%94.8万 | 180.56%20.2万 | -29.17%53.9万 | -53.06%241.4万 | 409.57%58.2万 |
| 营业外利息收入 | 2.08%245.9万 | 201.93%62.5万 | 0.00%59.7万 | -14.45%240.9万 | 0.00%58.9万 | -0.29%101.6万 | -0.96%20.7万 | -40.24%59.7万 | -53.85%281.6万 | 584.88%58.9万 |
| 营业外利息支出 | 514.63%205.9万 | 10,220.00%51.6万 | 601.72%40.7万 | -16.67%33.5万 | 2,814.29%20.4万 | 240.00%6.8万 | -96.35%5,000 | -75.63%5.8万 | -58.08%40.2万 | -97.45%7,000 |
| 投资净收益 | -745.16%-520万 | 120.33%105.3万 | 177.17%312.4万 | -95.05%80.6万 | 403.77%338.1万 | 30.76%665.2万 | -148.29%-517.9万 | -353.63%-404.8万 | -1.16%1,629.5万 | -134.63%-111.3万 |
| 被指定为现金流套期的金融工具损益 | ||||||||||
| 终止确认可供出售金融资产损益 | -485.9万 | 0 | ||||||||
| 联营企业及其他参股权益产生的收益 | ||||||||||
| 特殊收入(费用) | 810.07%4,038万 | 963.1万 | 9,639.37%2,108.2万 | 428.21%443.7万 | 282.14%321万 | 144.8万 | 0 | -22.1万 | -96.07%84万 | -96.10%84万 |
| 减:其他特殊费用 | -899.44%-4,434.5万 | ---963.1万 | -9,639.37%-2,108.2万 | -486.90%-443.7万 | ---321万 | ---144.8万 | --0 | --22.1万 | 96.46%-75.6万 | ---- |
| 减:勾销 | --396.5万 | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---8.4万 | ---- |
| 其他营业外收入(费用) | -97.18%96.9万 | -74.08%23.2万 | -99.22%25.9万 | 557.97%3,431.3万 | -49.84%48.4万 | -108.54%-21.6万 | 508.84%89.5万 | 2,007.44%3,315万 | -49.40%521.5万 | 154.58%96.5万 |
| 税前利润 | 31.55%3.13亿 | -50.72%4,601万 | -10.06%8,474.6万 | -30.99%2.38亿 | -51.18%8,189.4万 | -515.80%-3,144.3万 | -42.08%9,336.9万 | 1,015.92%9,422.8万 | 90.79%3.45亿 | 46.58%1.68亿 |
| 所得税 | 40.24%1.01亿 | -49.68%1,622.4万 | -21.06%2,545.3万 | -37.93%7,183.1万 | -70.67%1,596.9万 | -8,113.33%-862.4万 | -42.42%3,224.4万 | 499.41%3,224.2万 | 71.66%1.16亿 | 19.82%5,444.7万 |
| 除税后利润 | 27.80%2.12亿 | -51.27%2,978.6万 | -4.34%5,929.3万 | -27.49%1.66亿 | -41.81%6,592.6万 | -397.63%-2,281.9万 | -41.89%6,112.4万 | 1,922.38%6,198.6万 | 102.16%2.29亿 | 64.19%1.13亿 |
| 持续经营利润 | 27.80%2.12亿 | -51.27%2,978.6万 | -4.34%5,929.3万 | -27.49%1.66亿 | -41.81%6,592.5万 | -397.63%-2,281.9万 | -41.89%6,112.5万 | 1,922.38%6,198.6万 | 102.16%2.29亿 | 64.19%1.13亿 |
| 归属于少数股东的净利润 | ||||||||||
| 归属于母公司的净利润 | 27.80%2.12亿 | -51.27%2,978.6万 | -4.34%5,929.3万 | -27.49%1.66亿 | -41.81%6,592.6万 | -397.63%-2,281.9万 | -41.89%6,112.4万 | 1,922.38%6,198.6万 | 102.16%2.29亿 | 64.19%1.13亿 |
| 优先股派息 | ||||||||||
| 其他优先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 归属于普通股股东的净利润 | 27.80%2.12亿 | -51.27%2,978.6万 | -4.34%5,929.3万 | -27.49%1.66亿 | -41.81%6,592.6万 | -397.63%-2,281.9万 | -41.89%6,112.4万 | 1,922.38%6,198.6万 | 102.16%2.29亿 | 64.19%1.13亿 |
| 总派息金额 | ||||||||||
| 基本每股收益 | 27.80%120.31 | -51.27%16.87 | -4.33%33.58 | -27.48%94.14 | -41.80%37.34 | -397.70%-12.92 | -41.88%34.62 | 1,917.24%35.1 | 102.16%129.81 | 64.22%64.16 |
| 稀释每股收益 | 27.80%120.31 | -51.26%16.8697 | -4.33%33.58 | -27.48%94.14 | -41.80%37.3381 | -397.76%-12.9226 | -41.89%34.6152 | 1,917.24%35.1 | 102.16%129.81 | 64.22%64.16 |
| 每股派息 | 0.00%35 | 0 | 0 | 16.67%35 | 16.67%35 | 0 | 0 | 0 | 11.11%30 | 11.11%30 |
| 货币单位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
| 会计准则 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |